L514-0272 Screening compound: N~1~-(3-FLUOROPHENYL)-N~2~-[(2-PHENYL-1,3-THIAZOL-4-YL)METHYL]-1,2-PYRROLIDINEDICARBOXAMIDE

L514-0272 Screening compound: N~1~-(3-FLUOROPHENYL)-N~2~-[(2-PHENYL-1,3-THIAZOL-4-YL)METHYL]-1,2-PYRROLIDINEDICARBOXAMIDE
L514-0272 Screening compound: N~1~-(3-FLUOROPHENYL)-N~2~-[(2-PHENYL-1,3-THIAZOL-4-YL)METHYL]-1,2-PYRROLIDINEDICARBOXAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound L514-0272
N~1~-(3-FLUOROPHENYL)-N~2~-[(2-PHENYL-1,3-THIAZOL-4-YL)METHYL]-1,2-PYRROLIDINEDICARBOXAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L514-0272

Molecular Formula

C22H21FN4O2S (C22 H21 FN4 O2 S)

Compound Name

N~1~-(3-FLUOROPHENYL)-N~2~-[(2-PHENYL-1,3-THIAZOL-4-YL)METHYL]-1,2-PYRROLIDINEDICARBOXAMIDE

IUPAC name

(2R)-N1-(3-fluorophenyl)-N2-[(2-phenyl-13-thiazol-4-yl)methyl]pyrrolidine-12-dicarboxamide

SMILES

O=C(C(CCC1)N1C(Nc1cc(F)ccc1)=O)NCc1csc(-c2ccccc2)n1

InChI

InChI=1S/C22H21FN4O2S/c23-16-8-4-9-17(12-16)26-22(29)27-11-5-10-19(27)20(28)24-13-18-14-30-21(25-18)15-6-2-1-3-7-15/h1-4,6-9,12,14,19H,5,10-11,13H2,(H,24,28)(H,26,29)/t19-/m0/s1

InChI Key

HWZUMSPKPUSLBB-IBGZPJMESA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

424.5

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.787

Distribution Coefficient, logD

3.787

Water Solubility, LogSw

-3.95

Polar Surface Area

60.410

Acid Dissociation Constant (pKa)

12.61

Base Dissociation Constant (pKb)

0.59

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

22.73

L514-0272 in Drug Discovery

Included in Screening Libraries

3D Mimetics PPI Library (1617 compounds)

PI3K-Targeted Library (17255 compounds)

Protein-Protein Interaction Library (218420 compounds)

Targeted Diversity Library (40567 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Epigenetics Focused Set (26518 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Structure:
  • Mimetics
  • 3D
  • Cyclic compounds
Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with L514-0272 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L514-0272?
Check Price and Availability of L514-0272, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L514-0272 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L514-0272
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L514-0272
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L514-0272 available by request